According to the American College of Rheumatology, every year, around 302 million people around the world are affected by osteoarthritis, the most common form of arthritis. In addition, back pain and arthritis are two of the leading causes of work disability in the US. Although advancements in analgesics have been made in over the years, leading to the development of fast-acting gels, ointments, creams, and sprays that provide instant pain relief, there is still no effective long-term treatment for this condition.

But that may soon change thanks to the recent findings of a team of researchers at the Baylor College of Medicine in Houston, Texas, who conducted a study to assess the therapeutic effects of CBD in treating arthritic pain in dogs. The researchers hope that their findings can shed some light into how CBD might help humans afflicted with the same condition.

In the last five years, CBD has gained a lot of traction as an alternative form of treatment for a wide range of conditions and diseases, from insomnia to multiple sclerosis, although much of the hype has been a result of its anti-inflammatory properties, resulting in the introduction of an ever-expanding list of products that target muscle soreness and pain.

The study’s lead scientist, Dr. Matthew Halpert from Baylor’s Department of Pathology and Immunology, said, “CBD is rapidly increasing in popularity due to its anecdotal health benefits for a variety of conditions, from reducing anxiety to helping with movement disorders.”

In the study, Halpert and his co-researchers measured the effects of CBD on immune responses associated with arthritis, both in human and murine (mice) cells grown in the lab and in mouse models. They found that the CBD tinctures helped reduce the production of inflammatory molecules and immune cells linked to arthritis. In addition, they found that the CBD was more effective and the effect was quicker when the CBD was administered via encapsulated lipsomes rather than ‘naked’.

Following the favorable results observed in the mice models, they turned to assessing CBD’s effects on arthritic dogs. Halpert said of the decision, “We studied dogs because experimental evidence shows that spontaneous models of arthritis, particularly in domesticated canine models, are more appropriate for assessing human arthritis pain treatments than other animal models. The biological characteristics of arthritis in dogs closely resemble those of the human condition.”

For access to the full article please click-

Contributor- Jenna Meagher (A.P.C.C. Inc. Contributor)

For more information please

To Donate to the A.P.C.C.-